Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

MRK Merck and Co Inc

97,89

2,34 (2,45%)

28 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments

Both Shuttle Pharmaceuticals (Nasdaq:SHPH) and Northwest Biotherapeutics

To read the full story on AllPennyStocks.com, click here.

Merck (NYSE:MRK)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Merck Charts.

Merck (NYSE:MRK)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Merck Charts.

News Merck and Co Inc

FDA Grants Priority Review to Merck’s Application for WELIREG® (belzutifan) for the Treatment of Patients With Advanced Pheochromocytoma and Paraganglioma (PPGL)
Montag 27 Januar 2025 (14 Stunden vor) • Business Wire

Merck and Eisai Provide Update on Phase 3 LEAP-015 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Combination with Chemotherapy in Patients with Certain Types of Gastroesophageal Adenocarcinoma
Freitag 24 Januar 2025 (4 Tage vor) • Business Wire

Merck to Hold Fourth-Quarter and Full-Year 2024 Sales and Earnings Conference Call Feb. 4
Donnerstag 16 Januar 2025 (2 Wochen vor) • Business Wire

Investors Watching Two Small-Caps for News on Potential Major Advancements in Cancer Treatments
Montag 13 Januar 2025 (2 Wochen vor) • AllPennyStocks.com

Merck’s GARDASIL® Receives Expanded Approval for Males in China
Mittwoch 8 Januar 2025 (3 Wochen vor) • Business Wire

Merck to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Montag 6 Januar 2025 (3 Wochen vor) • Business Wire

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 3 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 3 Januar 2025 (3 Wochen vor) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Montag 23 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Weitere Merck and Co Inc News-Artikel

Agroindustrial Itapiranga PND

Applied Materials

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen